Rani TherapeuticsRANI
那斯達克 · USD
0.94
+0.02
(+2.56%)
收盤 04/25 03:59 (UTC+8)
04/25 03:59 (UTC+8)
Rani TherapeuticsRANI
0.94
+0.02
(+2.56%)
財務數據
損益表
- -
- -
- -
- -
- -
- 0.01
- 0.00
- -
- -
- 0.01
- -
- -
- -
- -
- -
- -
- -83.27
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 1,461 | - | - | 172 | 1,028 | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,461 | - | - | 172 | 1,028 | - | - | - | - | - |
營業費用 | 9,996 | 7,257 | 10,505 | 12,185 | 15,986 | - | 12,523 | - | 13,434 | 17,855 |
研發費用 | 4,909 | 3,221 | 5,505 | 6,570 | 6,810 | 6,172 | 6,114 | 7,586 | 7,606 | 11,220 |
推銷及管理費用 | 5,087 | 4,036 | 5,000 | 5,615 | 5,462 | 5,627 | 6,409 | 6,448 | 5,828 | 6,635 |
非經常性項目費用 | - | - | - | - | 3,714 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -8,535 | -7,257 | -10,505 | -12,013 | -14,958 | -11,799 | -12,523 | -14,034 | -13,434 | -17,855 |
其他收入及費用 | -192 | 68 | 157 | 218 | 360 | 415 | 439 | 549 | 675 | 839 |
利息費用 | 347 | 725 | 876 | 943 | 1,124 | 1,338 | 1,277 | 1,294 | 1,296 | 1,316 |
稅前純益 | -9,074 | -7,914 | -11,224 | -12,738 | -15,722 | -12,722 | -13,361 | -14,779 | -14,055 | -18,332 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -10,305 | -5,412 | -6,692 | -7,264 | -8,947 | -6,783 | -6,805 | -7,483 | -7,098 | -9,197 |
基本每股稅後盈餘(元) | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 | - | -0.36 |
稀釋每股稅後盈餘(元) | 0.05 | -0.10 | -0.18 | -0.22 | -0.27 | -0.23 | -0.26 | -0.29 | -0.27 | -0.36 |
基本平均股數(千股) | 147093.00 | 46444.00 | 36542.00 | 33440.00 | 32660.00 | 28836.00 | 26324.00 | 26034.00 | - | 25552.00 |
稀釋平均股數(千股) | 147093.00 | 46444.00 | 36542.00 | 33440.00 | 32660.00 | 28836.00 | 26324.00 | 26034.00 | - | 25552.00 |
還原基本每股稅後盈餘(元) | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 | -0.24 | -0.26 | -0.29 | - | -0.36 |
還原稀釋每股稅後盈餘(元) | 0.05 | -0.10 | -0.18 | -0.22 | -0.27 | -0.23 | -0.26 | -0.29 | -0.27 | -0.36 |
還原基本平均股數(千股) | 147,093 | 46,444 | 36,542 | 33,440 | 32,660 | 28,836 | 26,324 | 26,034 | - | 25,552 |
還原稀釋平均股數(千股) | 147,093 | 46,444 | 36,542 | 33,440 | 32,660 | 28,836 | 26,324 | 26,034 | - | 25,552 |
EBITDA(千元) | -9,859 | -4,406 | -5,526 | -6,162 | -7,806 | -5,438 | -5,505 | -6,223 | -5,982 | -8,214 |